Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial Groups
{{output}}
Introduction: Serum leucine-rich alpha-2 glycoprotein (LRG) has emerged as a novel biomarker for inflammatory bowel disease (IBD). However, its clinical utility among non-Japanese populations has not been investigated. This study... ...
